Re-engineering biopharmaceuticals for delivery to brain with molecular Trojan horses
- PMID: 18547095
- DOI: 10.1021/bc800148t
Re-engineering biopharmaceuticals for delivery to brain with molecular Trojan horses
Abstract
Biopharmaceuticals, including recombinant proteins, monoclonal antibody therapeutics, and antisense or RNA interference drugs, cannot be developed as drugs for the brain, because these large molecules do not cross the blood-brain barrier (BBB). Biopharmaceuticals must be re-engineered to cross the BBB, and this is possible with genetically engineered molecular Trojan horses. A molecular Trojan horse is an endogenous peptide, or peptidomimetic monoclonal antibody (mAb), which enters brain from blood via receptor-mediated transport on endogenous BBB transporters. Recombinant neurotrophins, single chain Fv antibodies, or therapeutic enzymes may be re-engineered as IgG fusion proteins. The engineering of IgG-avidin fusion proteins enables the BBB delivery of biotinylated drugs. The IgG fusion proteins are new chemical entities that are dual or triple function molecules that bind multiple receptors. The fusion proteins are able both to enter the brain, by binding an endogenous BBB receptor, and to induce the desired pharmacologic effect in brain, by binding target receptors in the brain behind the BBB. The development of molecular Trojan horses for BBB drug delivery allows the re-engineering of biopharmaceuticals that, owing to the BBB problem, could not otherwise be developed as new drugs for the human brain.
Similar articles
-
Reengineering biopharmaceuticals for targeted delivery across the blood-brain barrier.Methods Enzymol. 2012;503:269-92. doi: 10.1016/B978-0-12-396962-0.00011-2. Methods Enzymol. 2012. PMID: 22230573 Review.
-
Biopharmaceutical drug targeting to the brain.J Drug Target. 2010 Apr;18(3):157-67. doi: 10.3109/10611860903548354. J Drug Target. 2010. PMID: 20064077 Review.
-
Molecular Trojan horses for blood-brain barrier drug delivery.Curr Opin Pharmacol. 2006 Oct;6(5):494-500. doi: 10.1016/j.coph.2006.06.001. Epub 2006 Jul 12. Curr Opin Pharmacol. 2006. PMID: 16839816 Review.
-
Genetic engineering, expression, and activity of a fusion protein of a human neurotrophin and a molecular Trojan horse for delivery across the human blood-brain barrier.Biotechnol Bioeng. 2007 Aug 15;97(6):1376-86. doi: 10.1002/bit.21369. Biotechnol Bioeng. 2007. PMID: 17286273
-
A new generation of neurobiological drugs engineered to overcome the challenges of brain drug delivery.Drug News Perspect. 2008 Nov;21(9):489-503. doi: 10.1358/dnp.2008.21.9.1290820. Drug News Perspect. 2008. PMID: 19180267 Review.
Cited by
-
Comparison of blood-brain barrier transport of glial-derived neurotrophic factor (GDNF) and an IgG-GDNF fusion protein in the rhesus monkey.Drug Metab Dispos. 2009 Dec;37(12):2299-304. doi: 10.1124/dmd.109.028787. Epub 2009 Sep 9. Drug Metab Dispos. 2009. PMID: 19741036 Free PMC article.
-
A new liquid chromatography-mass spectrometry-based method to quantitate exogenous recombinant transferrin in cerebrospinal fluid: a potential approach for pharmacokinetic studies of transferrin-based therapeutics in the central nervous systems.Eur J Mass Spectrom (Chichester). 2015;21(3):369-76. doi: 10.1255/ejms.1365. Eur J Mass Spectrom (Chichester). 2015. PMID: 26307718 Free PMC article.
-
Peptide derived from HIV-1 TAT protein destabilizes a monolayer of endothelial cells in an in vitro model of the blood-brain barrier and allows permeation of high molecular weight proteins.J Biol Chem. 2012 Dec 28;287(53):44676-83. doi: 10.1074/jbc.M112.395384. Epub 2012 Nov 13. J Biol Chem. 2012. PMID: 23150670 Free PMC article.
-
Expression in CHO cells and pharmacokinetics and brain uptake in the Rhesus monkey of an IgG-iduronate-2-sulfatase fusion protein.Biotechnol Bioeng. 2011 Aug;108(8):1954-64. doi: 10.1002/bit.23118. Epub 2011 Mar 15. Biotechnol Bioeng. 2011. PMID: 21351076 Free PMC article.
-
Probing the brain with molecular fMRI.Curr Opin Neurobiol. 2018 Jun;50:201-210. doi: 10.1016/j.conb.2018.03.009. Epub 2018 Apr 9. Curr Opin Neurobiol. 2018. PMID: 29649765 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
